Neuroscientists believe that the presence of amyloid-beta is one of the key hallmarks of Alzheimer's. Research indicates that ...

Leqembi’s sales continue to be underwhelming, according to analysts, who contend the companies’ Alzheimer’s disease therapy ...

But poor sleep is both a risk factor for and a symptom of Alzheimer's disease, making it tricky to tease apart cause and ...

Zizyphi spinosi semen demonstrates neuroprotective effects, improving cognitive function and reducing amyloid and tau pathology in models of aging and dementia.

Q3 2024 Earnings Call Transcript November 6, 2024 Lantheus Holdings, Inc. beats earnings expectations. Reported EPS is $1.79, ...

This is crucial as the trial’s focus on TREM2 activation, which plays a role in the Amyloid beta pathway associated with Alzheimer’s, could lead to beneficial impacts on brain health beyond amyloid ...

In JAMA Neurology, the group challenged the "movement" to define Alzheimer's disease as a "purely biological entity based on biomarker findings." ...

Dr. Schacterle is a highly regarded leader who has successfully led global regulatory and quality activities across multiple neurologic and psychiatric therapeutic areas and all stages of development, ...

Staying active, eating healthier and considering medication can help manage hypertension and reduce dementia risk ...

After dosing with Cognition’s CT1812, study reports declines of 95% and higher in subgroup with below-median p-tau217.

A study from Wake Forest University has found that drinking alcohol, even in moderate amounts, may speed up the progression ...